Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Development — Salary and employee benefits by Year
Development — Salary and employee benefits ($M) ($M)
Vertex Pharmaceuticals Development — Salary and employee benefits: $745M in FY2025, up 8.5% from a year earlier. That is the highest of the 13 years on record here.
Where the FY2025 figure comes from
“|| Salary and benefits | $ 744.8 | 8% | $ 686.7 | 16% | $ 590.9”
Source: Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K MD&A (Development Expenses Disaggregation Table).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Development — Salary and employee benefits ($M), annual FY2013–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-dev-salary
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.